Human Pheromone Sciences Exclusive License Agreement for Its Initial Human Pheromone Technology in Taiwan

June 15, 2009

(Pact is the Company’s first in Southeast Asia, and provides for expanded relationship in Mainland China and other Asian Markets)

SAN JOSE, Calif., June 15 /PRNewswire-FirstCall/ — Human Pheromone Sciences, Inc. (OTC Bulletin Board: EROX) (“HPS” or “the Company”) today announced the signing of an exclusive License, Supply and Distribution Agreement (the “Agreement”) with Pheromone International CO., LTD., a Taiwan-based Company (“the Licensee”), an affiliate of David Bernard International, CO., LTD., for the use of the Company’s initial human pheromone technologies in personal care products to be developed and marketed in the Taiwan market. Under the Agreement, the Licensee must meet minimum annual purchase requirements to retain exclusivity in Taiwan for the four year period of the Agreement, and, if it is in compliance with annual minimums, will have the right of first opportunity for additional markets, including the Peoples Republic of China, Singapore and Macao, in all distribution channels, excluding Multi-Level Marketing.

“This agreement represents the culmination of several months of discussions between the parties, after the Licensee had conducted extensive market studies and legal reviews to ascertain and confirm the potential for the success of consumer products containing these compounds in Southeast Asian markets,” a Company spokesperson noted. A spokesperson for the Licensee stated, “we have conducted in-depth marketing and research studies in the Asian markets over the past four years. We plan to develop lines of consumer products to be distributed through our own channels, and sublicense the use of the pheromones to other companies with additional methods of distribution. We want to act as the exclusive agent for Human Pheromone Sciences, Inc. in Taiwan and Mainland China because we recognize that they are the only Company that has the scientific proof of the effects of their compounds, and the claims have been validated in leading universities around the world; to establish the Company’s brand image, we will utilize exhibition spaces in major department stores, and the Carrefour Mall, as well as the internet and Electronic Media. We plan to be a pheromone leader in Taiwan and Mainland China, and this agreement is the catalyst,” the Licensee’s spokesperson said.

Major current clients of the Licensee include Sony Ericsson in Taiwanese department stores, fifty-seven retailers in the Carrefour Mall in Taiwan, and several boutique hotels in Taiwan and Mainland China.

Human Pheromone Sciences, Inc. is a technology-based company, whose proof-of concept products included prestige-priced fragrances and toiletries and environmental products sold under the Natural Attraction(R), REALM(R), innerREALM(R) and EROX(R) trademarks. These products contain mood-enhancing compounds, whose efficacy has been validated at leading universities around the world, and whose use is covered under United States and foreign patents. The Company is also involved in research and product development efforts on new compounds that have been previously identified as stimulating the emotional centers of the human brain. Further information is available online at www.erox.com and www.er303.com .

The statements in this news release may contain forward-looking statements that involve risks and uncertainties that could cause results to differ from predicted results. Further information on factors that could affect the Company’s results is detailed in the Company’s annual report to shareholders on Form 10-K for the year ended December 31, 2008, and Form 10-Q for the quarter ended March 31, 2009, as filed with the Securities and Exchange Commission. The Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements.

SOURCE Human Pheromone Sciences, Inc.

Source: newswire

comments powered by Disqus